Source: International Congress 2015 – Quality management in lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Haval Balata (Manchester, United Kingdom), Haval Balata, Matthew Evison, Julie Morris, Haider Al-Najjar, Phil Barber, Philip Crosbie, Richard Booton. Is there equitable access to PET-CT for lung cancer patients across a large UK cancer network; a retrospective study of 4597 patients. Eur Respir J 2015; 46: Suppl. 59, 4234

Member's Comments

No comment yet.

Related content which might interest you: Improving survival for NSCLC patients in the national lung cancer audit Source: International Congress 2015 – Quality management in lung cancer Year: 2015 Should resection rate increase when PET-CT use increases? An analysis of PET-CT use in large UK lung cancer network 2011 - 2013 Source: International Congress 2015 – Quality management in lung cancer Year: 2015 Lung cancer in patients before the age of 45: A retrospective analysis of 62 patients Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features Year: 2015 Predictors of lung cancer patients delay time in Serbia - a cross-sectional study Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014 A feasibility study: Home-telemonitoring for rural lung cancer patients Source: Annual Congress 2013 –Respiratory nursing care: assessment, interventions and education Year: 2013 Analysis of PET-CT use across a UK cancer network: Are we adhering to NICE guidelines? Source: International Congress 2015 – Quality management in lung cancer Year: 2015 Impact of PET scan on staging and management of lung cancer patients in Indian scenario Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer Year: 2013 A survey of outcome of CT guided lung biopsies in a tertiary centre Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer Year: 2013 Treatment and survival in patients with pulmonary carcinoid tumours; an updated analysis from the UK national lung cancer audit Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features Year: 2015 Should all lung cancer patients requiring pathological nodal staging undergo PET-CT first? Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 The role of second line chemotherapy in small cell lung cancer: A retrospective analysis Source: Annual Congress 2013 –Advances in the therapy of lung cancer Year: 2013 Should preoperative FDG uptake on PET/CT guide postoperative surveillance in surgical non-small cell lung cancer (NSCLC) Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016 Diagnosing lung cancer: Choosing the best for your patient Source: International Congress 2015 – Developments in lung cancer diagnosis Year: 2015 Reducing the rate of emergency presentation in lung cancer Source: International Congress 2015 – Quality management in lung cancer Year: 2015 Patient and doctor delays in the diagnosis and treatment of non-small cell lung cancer in Turkey Source: Annual Congress 2013 –Quality management in thoracic oncology Year: 2013 Impact of second-line treatment on overall survival of advanced lung adenocarcinoma patients Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016 Incidental findings on PET-CT scans; how they are managed and how they impact on the lung cancer pathway Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Single-institution experience of surgical management of metastasises of colorectal cancer in lungs: Lessons learned Source: Annual Congress 2013 –Oncological thoracic surgery Year: 2013 Should CT-guided biopsy for suspected lung cancer be delayed pending PET/CT results? Source: International Congress 2016 – Transbronchial diagnostics: from ILD to pheripheral lesions Year: 2016 Lung cancer risk prediction model based on data of the SOS trial (single center non-randomized lung cancer early detection trial) Source: International Congress 2014 – Risk assessment and tracheal reconstructions Year: 2014